ATRX and thyroid cancer: Conversely, ALT mechanisms as determined by mutations in ATRX and DAXX, are not reported in non-medullary cells derived thyroid cancers in many different studies [6,11,118], thus an involvement of these mechanisms in telomere deregulation may be likely excluded in this pathogenic environment.